NTUS
NASDAQ:NTUS
Natus Medical Incorporated
- Stock
Last Close
32.96
01/01 00:00
Volume Today
132.70K
Avg: 339.69K
PE Ratio
84.22
PFCF: -
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 344.11M - | 355.83M 3.41% | 375.87M 5.63% | 381.89M 1.60% | 500.97M 31.18% | 530.89M 5.97% | 495.18M 6.73% | 415.68M 16.05% | 473.44M 13.89% | |
cost of revenue | 142.08M - | 141.45M 0.45% | 148.33M 4.86% | 146.96M 0.92% | 219.76M 49.54% | 226.88M 3.24% | 203.47M 10.32% | 199.15M 2.12% | 199.76M 0.30% | |
gross profit | 202.03M - | 214.39M 6.12% | 227.54M 6.13% | 234.93M 3.25% | 281.21M 19.70% | 304.01M 8.11% | 291.71M 4.05% | 216.53M 25.77% | 273.68M 26.39% | |
selling and marketing expenses | 87.15M - | 87.47M 0.37% | 87.67M 0.23% | 84.83M 3.24% | 126.17M 48.72% | 136.68M 8.33% | 129.11M 5.54% | 107.28M 16.91% | 116.01M 8.14% | |
general and administrative expenses | 48.53M - | 49.28M 1.54% | 46.36M 5.91% | 50.88M 9.74% | 74.42M 46.28% | 68.70M 7.69% | 59.65M 13.17% | 49.11M 17.66% | 52.75M 7.41% | |
selling general and administrative expenses | 135.68M - | 136.75M 0.79% | 134.04M 1.98% | 135.71M 1.25% | 200.59M 47.81% | 205.38M 2.39% | 188.76M 8.09% | 156.40M 17.15% | 168.77M 7.91% | |
research and development expenses | 32.07M - | 31.79M 0.89% | 30.43M 4.26% | 33.44M 9.89% | 51.82M 54.96% | 61.48M 18.64% | 58.73M 4.47% | 61.30M 4.36% | 56.31M 8.14% | |
other expenses | 7.45M - | 8.98M 20.63% | 19.17M 113.41% | 24.48M 27.72% | 15.14M 38.15% | 15.22M 0.53% | 17.13M 12.51% | |||
cost and expenses | 309.83M - | 309.98M 0.05% | 320.25M 3.31% | 325.10M 1.51% | 491.34M 51.14% | 518.22M 5.47% | 466.10M 10.06% | 432.07M 7.30% | 441.96M 2.29% | |
operating expenses | 167.75M - | 168.54M 0.47% | 171.92M 2.01% | 178.14M 3.62% | 271.58M 52.46% | 291.35M 7.28% | 262.63M 9.85% | 232.91M 11.32% | 242.20M 3.99% | |
interest expense | 1.68M - | 438K 73.85% | 352K 19.63% | 430K 22.16% | 5.08M 1,081.63% | 6.79M 33.71% | 4.94M 27.27% | 3.66M 26.01% | 1.87M 48.80% | |
ebitda | 46.09M - | 58.21M 26.30% | 68.75M 18.11% | 72.21M 5.04% | 40.33M 44.15% | 8.40M 79.18% | 14.41M 71.56% | 9.71M 32.63% | 49.32M 408.12% | |
operating income | 34.28M - | 45.85M 33.76% | 53.47M 16.62% | 55.26M 3.34% | 8.72M 84.23% | -24.56M 381.77% | -15.67M 36.22% | -20.19M 28.90% | 21.23M 205.12% | |
depreciation and amortization | 12.85M - | 11.76M 8.48% | 15.99M 35.96% | 16.88M 5.58% | 30.10M 78.32% | 33.86M 12.51% | 30.72M 9.28% | 28.11M 8.49% | 28.09M 0.09% | |
total other income expenses net | -2.72M - | 158K 105.82% | -1.06M 773.42% | -357K 66.45% | -3.57M 899.16% | -7.70M 115.81% | -5.59M 27.37% | -1.87M 66.52% | -1.87M 0% | |
income before tax | 31.56M - | 46.01M 45.77% | 52.41M 13.91% | 54.90M 4.76% | 5.15M 90.62% | -32.26M 726.41% | -21.26M 34.11% | -22.07M 3.80% | 19.36M 187.72% | |
income tax expense | 8.69M - | 13.53M 55.80% | 14.48M 7.05% | 12.31M 15.02% | 25.44M 106.70% | -9.32M 136.65% | -5.59M 40.10% | -5.45M 2.40% | 6.18M 213.32% | |
net income | 22.88M - | 32.48M 41.96% | 37.92M 16.77% | 42.59M 12.31% | -20.29M 147.64% | -22.93M 13.02% | -15.67M 31.67% | -16.61M 6.01% | 13.18M 179.32% | |
weighted average shs out | 29.99M - | 31.50M 5.02% | 32.35M 2.70% | 32.46M 0.35% | 32.56M 0.32% | 33.11M 1.68% | 33.70M 1.77% | 33.56M 0.40% | 33.97M 1.23% | |
weighted average shs out dil | 30.82M - | 32.57M 5.67% | 33.24M 2.07% | 33.06M 0.56% | 32.56M 1.49% | 33.11M 1.68% | 33.70M 1.77% | 33.56M 0.40% | 33.97M 1.23% | |
eps | 0.76 - | 1.03 35.53% | 1.17 13.59% | 1.31 11.97% | -0.62 147.33% | -0.69 11.29% | -0.47 31.88% | -0.49 4.26% | 0.39 179.59% | |
epsdiluted | 0.74 - | 1 35.14% | 1.14 14.00% | 1.29 13.16% | -0.62 148.06% | -0.69 11.29% | -0.47 31.88% | -0.49 4.26% | 0.39 179.59% |
All numbers in USD (except ratios and percentages)